+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Generic Injectables Market - Global Forecast 2026-2032- Product Image
Generic Injectables Market - Global Forecast 2026-2032- Product Image
New

Generic Injectables Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887534
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The generic injectables market is evolving rapidly as manufacturers, distributors, and healthcare systems face growing pressure to ensure supply reliability, regulatory compliance, and clinical efficiency. The following report distills key trends, segmentation insights, and actionable strategies to support targeted decision-making.

Market Snapshot: Generic Injectables Market Growth and Opportunities

The Generic Injectables Market grew from USD 40.14 billion in 2025 to USD 44.05 billion in 2026, with an expected CAGR of 11.14%, reaching USD 84.10 billion by 2032. This industry remains critical for acute care, chronic disease management, and perioperative therapies, driven by rising demand for cost management and supply chain continuity within healthcare delivery models.

Scope & Segmentation Analysis

  • Distribution Channels: Direct tender, hospital pharmacy, online (B2C platforms, e-pharmacies), and retail outlets.
  • Dosage Forms: Includes emulsion, lyophilized powder, solution, and suspension, each with specific cold-chain and sterility considerations.
  • Drug Classes: Analgesics, anesthetics, antibiotics (including aminoglycosides, beta-lactams, glycopeptides), cardiovascular agents, and oncology agents (cytotoxics, monoclonal antibodies).
  • End Users: Ambulatory surgical centers, hospital pharmacies, retail pharmacies, clinics (community, specialty).
  • Large Volume Parenterals: Bag and bottle presentations tailored for institutional buyers.
  • Molecule-Level Focus: Active molecules such as cefuroxime, fentanyl, meropenem, oxaliplatin, and vancomycin.
  • Packaging Types: Ampoules, cartridges, pre-filled syringes (safety and standard), vials.
  • Product Types: Ampoule, pre-filled syringe, vial.
  • Route of Administration: Intramuscular, intravenous, subcutaneous use cases aligned with varied care settings.
  • Therapeutic Applications: Anesthesia, anti-infective (antibiotics, antivirals), cardiovascular, oncology (cytotoxic agents, targeted therapies), pain management (opioids, non-opioids).

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Supply chain resilience and supplier diversification are central to mitigating disruption risks and maintaining product availability in the generic injectables market.
  • Regulatory agencies continue to intensify scrutiny of sterile manufacturing operations, prompting firms to upgrade quality systems and adopt proactive risk management practices.
  • Procurement behaviors are shifting towards vendor selection based on manufacturing transparency, delivery performance, and total cost evaluation, rather than price alone.
  • Adoption of advanced packaging technologies, such as pre-filled and safety-engineered syringes, supports clinical workflow efficiency and error reduction in high-acuity environments.
  • Regional market dynamics demand locally adapted approaches, with investments in quality oversight and supply localization benefitting manufacturers in diversified regulatory landscapes.

Tariff Impact on Supply Strategy and Contracting

Recent United States tariff measures introduce complex economic considerations for generic injectables stakeholders. These tariffs influence supplier selection, distribution economics, and contract terms, driving organizations to assess nearshoring, supplier diversification, and collaborative procurement methods. As input costs rise, procurement teams focus on refining supply agreements and evaluating opportunities for cost containment and resilience planning across their injectable product portfolios.

Primary Keyword: Generic Injectables Market

Methodology & Data Sources

The findings leverage structured interviews with manufacturers, hospital pharmacy directors, and regulatory experts, combined with secondary analysis of regulatory standards and market literature. Segmentation analysis and scenario-based risk assessments enable a holistic evaluation of sourcing, operations, and contractual trends. Methodological transparency addresses regulatory shifts and the impact of changing trade policies.

Why This Report Matters: Decision-Making Advantages

  • Identifies which market segments offer the highest operational resilience and growth potential for your organization.
  • Highlights procurement and supply chain adjustments proven to secure reliable access to essential injectables in a volatile regulatory context.
  • Supports better-informed capital allocation and partnership choices for long-term market positioning.

Conclusion

Sustaining reliable access to generic injectables depends on operational excellence, transparent sourcing, and alignment with clinician and procurement needs. This report enables senior leaders to navigate market complexity and build competitive, future-ready strategies.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Generic Injectables Market, by Drug Class
8.1. Anti Infectives
8.1.1. Antibacterials
8.1.2. Antivirals
8.1.3. Antifungals
8.1.4. Antiparasitics
8.2. Cardiovascular Agents
8.2.1. Antihypertensives
8.2.2. Antiarrhythmics
8.2.3. Antithrombotic Agents
8.3. Central Nervous System Agents
8.3.1. Antiepileptics
8.3.2. Antipsychotics
8.3.3. Anxiolytics
8.4. Hormonal Agents
8.4.1. Insulins
8.4.2. Gonadal Hormones
8.5. Oncology Agents
8.5.1. Cytotoxic Agents
8.5.2. Targeted Therapies
8.5.3. Supportive Care Oncology Agents
8.6. Analgesics And Anesthetics
8.6.1. Opioid Analgesics
8.6.2. Non Opioid Analgesics
8.6.3. General Anesthetics
8.6.4. Local Anesthetics
8.7. Hematology Agents
8.7.1. Hemostatics
8.7.2. Hematinics
8.8. Immunomodulators
8.8.1. Immunosuppressants
8.8.2. Immunostimulants
8.9. Gastrointestinal Agents
8.9.1. Anti Ulcerants
8.9.2. Antiemetics
8.9.3. Prokinetics
9. Generic Injectables Market, by Route Of Administration
9.1. Intravenous
9.2. Intramuscular
9.3. Subcutaneous
9.4. Intradermal
9.5. Intrathecal
9.6. Intra Articular
9.7. Intra Peritoneal
10. Generic Injectables Market, by Dosage Form
10.1. Solution
10.1.1. Ready To Use
10.1.2. Concentrate For Dilution
10.2. Suspension
10.3. Emulsion
10.4. Lyophilized Powder
10.4.1. For Bolus Injection
10.4.2. For Infusion
10.5. Depot Injection
10.6. Liposomal Formulation
11. Generic Injectables Market, by Container Type
11.1. Vials
11.1.1. Single Dose Vials
11.1.2. Multi Dose Vials
11.2. Ampoules
11.3. Prefilled Syringes
11.4. Cartridges
11.5. Bags
11.6. Pens And Auto Injectors
12. Generic Injectables Market, by Distribution Channel
12.1. Hospital Pharmacies
12.2. Retail Pharmacies
12.3. Online Pharmacies
12.4. Institutional Purchasing Organizations
13. Generic Injectables Market, by Therapeutic Area
13.1. Oncology
13.1.1. Solid Tumors
13.1.2. Hematologic Malignancies
13.1.3. Supportive Care
13.2. Anti Infective
13.2.1. Antibacterial
13.2.2. Antiviral
13.2.3. Antifungal
13.2.4. Antiparasitic
13.3. Cardiovascular
13.3.1. Hypertension
13.3.2. Heart Failure
13.3.3. Arrhythmia
13.3.4. Antithrombotic Therapy
13.4. Central Nervous System
13.4.1. Anesthesia
13.4.2. Pain Management
13.4.3. Epilepsy
13.4.4. Psychiatric Disorders
13.5. Endocrinology And Metabolic
13.5.1. Diabetes
13.5.2. Thyroid Disorders
13.6. Gastrointestinal
13.6.1. Acid Related Disorders
13.6.2. Inflammatory Bowel Disease
13.7. Respiratory
13.7.1. Asthma
13.7.2. Chronic Obstructive Pulmonary Disease
13.8. Immunology
13.8.1. Autoimmune Disorders
13.8.2. Transplant Rejection Prophylaxis
13.9. Hematology Non Oncology
13.9.1. Anemia
13.9.2. Coagulation Disorders
14. Generic Injectables Market, by End User
14.1. Hospitals
14.1.1. Public Hospitals
14.1.2. Private Hospitals
14.2. Ambulatory Surgical Centers
14.3. Clinics
14.4. Home Healthcare
14.5. Diagnostic And Imaging Centers
15. Generic Injectables Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Generic Injectables Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Generic Injectables Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Generic Injectables Market
19. China Generic Injectables Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Amgen Inc.
20.6. AstraZeneca PLC
20.7. Aurobindo Pharma Limited
20.8. Baxter International Inc.
20.9. Biocon Limited
20.10. Biological E. Limited
20.11. Bristol-Myers Squibb Company
20.12. Cipla Limited
20.13. Dr. Reddy's Laboratories Ltd.
20.14. Endo, Inc.
20.15. Fresenius Kabi AG
20.16. Gland Pharma Limited by Shanghai Fosun Pharmaceutical Co., Ltd.
20.17. GlaxoSmithKline PLC
20.18. Hikma Pharmaceuticals PLC
20.19. Johnson & Johnson Services, Inc.
20.20. Lupin Limited
20.21. Meitheal Pharmaceuticals, Inc.
20.22. Merck & Co. Inc.
20.23. Novartis AG
20.24. Novo Nordisk A/S
20.25. Pfizer Inc.
20.26. Samsung Biologics Co., Ltd.
20.27. Sanofi S.A.
20.28. Somerset Pharma, LLC by Mylan
20.29. Sun Pharmaceutical Industries Ltd.
20.30. Teva Pharmaceutical Industries Ltd.
20.31. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL GENERIC INJECTABLES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GENERIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GENERIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CONTAINER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES GENERIC INJECTABLES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA GENERIC INJECTABLES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GENERIC INJECTABLES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBACTERIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBACTERIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBACTERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIPARASITICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIPARASITICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR AGENTS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIHYPERTENSIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIHYPERTENSIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIHYPERTENSIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIARRHYTHMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIARRHYTHMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIARRHYTHMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTITHROMBOTIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTITHROMBOTIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTITHROMBOTIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM AGENTS, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIEPILEPTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIEPILEPTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIEPILEPTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIPSYCHOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIPSYCHOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANXIOLYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANXIOLYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANXIOLYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HORMONAL AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HORMONAL AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HORMONAL AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HORMONAL AGENTS, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INSULINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INSULINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INSULINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GONADAL HORMONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GONADAL HORMONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GONADAL HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CYTOTOXIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CYTOTOXIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CYTOTOXIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TARGETED THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TARGETED THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUPPORTIVE CARE ONCOLOGY AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUPPORTIVE CARE ONCOLOGY AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUPPORTIVE CARE ONCOLOGY AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANALGESICS AND ANESTHETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANALGESICS AND ANESTHETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANALGESICS AND ANESTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANALGESICS AND ANESTHETICS, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY OPIOID ANALGESICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY OPIOID ANALGESICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY OPIOID ANALGESICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY NON OPIOID ANALGESICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY NON OPIOID ANALGESICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY NON OPIOID ANALGESICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GENERAL ANESTHETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GENERAL ANESTHETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GENERAL ANESTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LOCAL ANESTHETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LOCAL ANESTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMATOLOGY AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMATOLOGY AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMATOLOGY AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMATOLOGY AGENTS, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMOSTATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMOSTATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMOSTATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMATINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMATINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMATINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOMODULATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOMODULATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOMODULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOMODULATORS, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOSTIMULANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOSTIMULANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOSTIMULANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GASTROINTESTINAL AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GASTROINTESTINAL AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GASTROINTESTINAL AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GASTROINTESTINAL AGENTS, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI ULCERANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI ULCERANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI ULCERANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIEMETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIEMETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIEMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PROKINETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PROKINETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PROKINETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRADERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRADERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRATHECAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRATHECAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRATHECAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRA ARTICULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRA ARTICULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRA ARTICULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRA PERITONEAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRA PERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRA PERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SOLUTION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY READY TO USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY READY TO USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY READY TO USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CONCENTRATE FOR DILUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CONCENTRATE FOR DILUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CONCENTRATE FOR DILUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY EMULSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY EMULSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY EMULSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY FOR BOLUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY FOR BOLUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY FOR BOLUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY FOR INFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY FOR INFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY FOR INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DEPOT INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DEPOT INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DEPOT INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LIPOSOMAL FORMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LIPOSOMAL FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LIPOSOMAL FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VIALS, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SINGLE DOSE VIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SINGLE DOSE VIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SINGLE DOSE VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MULTI DOSE VIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MULTI DOSE VIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MULTI DOSE VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMPOULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY BAGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY BAGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PENS AND AUTO INJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PENS AND AUTO INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PENS AND AUTO INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INSTITUTIONAL PURCHASING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INSTITUTIONAL PURCHASING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INSTITUTIONAL PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUPPORTIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUPPORTIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI INFECTIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 226. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI INFECTIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI INFECTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI INFECTIVE, 2018-2032 (USD MILLION)
TABLE 229. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIVIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIVIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIVIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIFUNGAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIFUNGAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIPARASITIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIPARASITIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIPARASITIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HYPERTENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 247. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HYPERTENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 250. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 252. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ARRHYTHMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 253. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ARRHYTHMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 254. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTITHROMBOTIC THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 255. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTITHROMBOTIC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 256. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTITHROMBOTIC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 259. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 260. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 261. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 262. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 263. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 264. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 265. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 266. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 268. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 269. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 271. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 272. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 273. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ENDOCRINOLOGY AND METABOLIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 274. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ENDOCRINOLOGY AND METABOLIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 275. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ENDOCRINOLOGY AND METABOLIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 276. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ENDOCRINOLOGY AND METABOLIC, 2018-2032 (USD MILLION)
TABLE 277. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 278. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 279. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY THYROID DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 281. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY THYROID DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 282. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY THYROID DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 284. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 285. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 287. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ACID RELATED DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 288. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ACID RELATED DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 289. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ACID RELATED DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 290. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 291. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 292. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 293. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 294. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 295. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 296. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 297. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 298. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ASTHMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 299. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ASTHMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 300. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 301. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 302. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 303. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 304. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 305. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 306. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 307. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 308. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 309. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 310. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TRANSPLANT REJECTION PROPHYLAXIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 311. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TRANSPLANT REJECTION PROPHYLAXIS, BY GROUP, 2018-2032 (USD M

Companies Mentioned

The key companies profiled in this Generic Injectables market report include:
  • Amgen Inc.
  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Baxter International Inc.
  • Biocon Limited
  • Biological E. Limited
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Endo, Inc.
  • Fresenius Kabi AG
  • Gland Pharma Limited by Shanghai Fosun Pharmaceutical Co., Ltd.
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Meitheal Pharmaceuticals, Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Samsung Biologics Co., Ltd.
  • Sanofi S.A.
  • Somerset Pharma, LLC by Mylan
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 44.05 Billion
Forecasted Market Value ( USD ) by 2032 $ 84.1 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Generic Injectables Market Report and Forecast 2025-2034 - Product Image

Generic Injectables Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Generic Injectables - Global Strategic Business Report - Product Image

Generic Injectables - Global Strategic Business Report

  • Report
  • 602 Pages
  • Global
From
Generic Injectables: Market Share, and Growth Analysis by Product Type (Powder Injectables, Liquid Injectables, Pre-filled Syringes), Application, End User, Technology - Product Image

Generic Injectables: Market Share, and Growth Analysis by Product Type (Powder Injectables, Liquid Injectables, Pre-filled Syringes), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Injectable Ketamine Market - Global Forecast 2025-2030 - Product Image

Injectable Ketamine Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Generic Oncology Sterile Injectable Market Report 2025 - Product Image

Generic Oncology Sterile Injectable Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Generic Injectable Market

The Generic Injectable market is a segment of the drug delivery industry that focuses on the production and distribution of generic injectable drugs. These drugs are typically administered via injection and are used to treat a variety of medical conditions. Generic injectables are typically cheaper than their branded counterparts, making them a popular choice for patients and healthcare providers alike. Generic injectables are typically produced in bulk and then packaged and distributed to pharmacies and hospitals. The production process involves the use of sterile manufacturing techniques and quality control measures to ensure the safety and efficacy of the drugs. Generic injectables are an important part of the drug delivery industry, as they provide an affordable and effective way to treat a variety of medical conditions. Some companies in the Generic Injectable market include Hospira, Mylan, Teva Pharmaceuticals, Sandoz, and Fresenius Kabi. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.